news
Novartis announces new CEO
Novartis announces CEO Joseph Jimenez to retire from Novartis in…
Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018.
List view / Grid view
Joseph Jimenez
news
Novartis releases 2013 Corporate Responsibility Performance Report using best-in-class reporting standard, increasing transparency
Novartis has published a Corporate Responsibility (CR) Performance Report for…
9 July 2014 | By Novartis
Novartis has published a Corporate Responsibility (CR) Performance Report for 2013...
news
Novartis emphasizes new focused portfolio at its first Meet Novartis Management investor day
For its first "Meet Novartis Management" investor day, Novartis gathered…
18 June 2014 | By Novartis
For its first "Meet Novartis Management" investor day, Novartis gathered more than 20 of its top executives, drawn from the leadership of Pharmaceuticals...
news
Novartis appoints Jeff George as Division Head, Alcon as Kevin Buehler retires; Richard Francis named as new Division Head, Sandoz
Novartis announced the appointment of Jeff George as Division Head…
9 April 2014 | By Novartis
Novartis announced the appointment of Jeff George as Division Head of Alcon, effective May 1, 2014...
news
Novartis and Malaria No More provide two million antimalarial treatments to children in Zambia
Novartis announced that two million treatments of its pediatric antimalarial…
7 April 2014 | By Novartis
Novartis announced that two million treatments of its pediatric antimalarial are arriving in Zambia thanks to the ongoing efforts of the company in collaboration with Malaria No More's Power of One campaign...
news
Novartis recognized among world’s most sustainable companies in Corporate Knights Global 100
Novartis is pleased to announce that it has been named…
27 January 2014 | By Novartis
Novartis is pleased to announce that it has been named among the 2014 Corporate Knights Global 100...
news
Novartis Foundation launches new leprosy strategy at symposium on disease elimination
Experts present lessons learned from past control programs and new…
29 November 2013 | By Novartis
Experts present lessons learned from past control programs and new approaches to eliminating diseases such as leprosy and malaria...
news
Novartis holds annual healthcare entrepreneur competition to generate insight into healthcare and innovation of tomorrow
Novartis has invited 60 selected students from leading international universities…
26 August 2013 | By Novartis
Novartis has invited 60 selected students from leading international universities in 21 countries to its headquarters in Switzerland for the International Biotechnology Leadership Camp...
news
Novartis first company accredited with global “CEO Cancer Gold Standard” for outstanding efforts in cancer prevention and treatment
"At Novartis, we believe that everyone should have access to…
8 August 2013 | By Novartis
"At Novartis, we believe that everyone should have access to early screening programs and innovative therapies..."
news
Novartis signs on to support Malaria No More’s Power of One campaign to stride towards a future without malaria
"We believe that this innovative campaign will help speed malaria…
25 April 2013 | By Novartis
"We believe that this innovative campaign will help speed malaria elimination..."
news
Novartis makes progress in the fight to eliminate leprosy worldwide
"The challenges in delivering healthcare in developing countries are considerable..."
17 January 2013 | By Novartis
"The challenges in delivering healthcare in developing countries are considerable..."
news
Novartis Foundation symposium discusses psychosocial support for Africa’s children
Healthcare experts assess psychosocial approaches and interventions...
4 December 2012 | By Novartis
Healthcare experts assess psychosocial approaches and interventions...
news
Novartis future growth prospects secured by industry-leading pipeline, with more than 139 projects with 73 new compounds
Update on leading R&D pipeline...
8 November 2012 | By Novartis
Update on leading R&D pipeline...
news
Novartis to start construction of new biotechnology facility in Singapore with an investment of over USD 500 million
Novartis announced the construction of a new state-of-the-art biotechnology production…
31 October 2012 | By Novartis
Novartis announced the construction of a new state-of-the-art biotechnology production site...
news
Novartis International BioCamp highlights global R&D reach to meet patient needs in emerging markets
Novartis welcomed its annual International Biotechnology Leadership Camp...
29 August 2012 | By Novartis
Novartis welcomed its annual International Biotechnology Leadership Camp...
